Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

BeiGene Ltd. (BGNE)

121.17   -1.74 (-1.42%) 07-16 16:00
Open: 122.9 Pre. Close: 122.91
High: 122.9 Low: 118.7
Volume: 163,014 Market Cap: 7162M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 127.739 - 128.23 128.23 - 128.794
Low: 120.018 - 120.532 120.532 - 121.122
Close: 121.951 - 122.779 122.779 - 123.73

Technical analysis

as of: 2019-07-16 3:19:13 PM
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 145.48     One year: 153.81
Support: Support1: 113.01    Support2: 94.02
Resistance: Resistance1: 124.55    Resistance2: 131.69
Pivot: 125.20
Moving Average: MA(5): 122.74     MA(20): 123.86
MA(100): 129.14     MA(250): 139.07
MACD: MACD(12,26): -0.02     Signal(9): 0.35
Stochastic oscillator: %K(14,3): 26.97     %D(3): 30.31
RSI: RSI(14): 44.60
52-week: High: 194.56  Low: 105.19  Change(%): -26.0
Average Vol(K): 3-Month: 27798  10-Days: 21292

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
BGNE has closed above bottom band by 16.0%. Bollinger Bands are 51.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to BGNE's normal range. The bands have been in this narrow range for 4 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Fri, 12 Jul 2019 18:08:50 Z
Here's Why BeiGene Lost 11.6% in the First Half of 2019

Tue, 09 Jul 2019 12:07:51 Z
3 Top Chinese Stocks to Watch in July

Mon, 08 Jul 2019 16:11:15 Z
Why Bristol-Myers Squibb Stock Plunged in the First Half of 2019

Mon, 08 Jul 2019 14:08:22 Z
We Did The Math FNI Can Go To $42

Wed, 26 Jun 2019 23:08:28 Z
The 2 Biggest Casualties From the Celgene-Bristol-Myers Merger (So Far)

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 59.90
Shares Float (M) 30.73
% Held by Insiders 0.03
% Held by Institutions 88.60
Shares Short (K) 3630
Shares Short P. Month (K)

Stock Financials

EPS -12.830
EPS Est. Current Year -3.900
EPS Est. Next Year -4.990
EPS Est. Next Quarter 0.160
Forward EPS -7.070
Book Value (p.s.) 26.910
PEG Ratio -0.42
Profit Margin
Operating Margin -315.68
Return on Assets (ttm) -24.8
Return on Equity (ttm) -49.4
Qtrly Rev. Growth 139.2
Gross Profit (p.s.) -8.506
Sales Per Share
EBITDA (p.s.) -12.640
Qtrly Earnings Growth
Operating Cash Flow (M) -615.19
Levered Free Cash Flow (M) -523.54

Stock Valuations

P/E -9.47
P/E Growth Ratio -0.01
P/BV 4.51
P/S 1716191488.00
P/CF -11.83

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.